These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9457156)

  • 41. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term results of treatment of obesity].
    Wechsler JG; Ditschuneit H
    Med Klin; 1980 Jul; 75(15):544-50. PubMed ID: 7001202
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 44. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fifty-seven-year-old man with progressive dyspnoea.
    Koshkelashvili N; Kohli P; Linefsky J
    Heart; 2019 Apr; 105(7):544-578. PubMed ID: 30467193
    [No Abstract]   [Full Text] [Related]  

  • 46. Effective management of obesity.
    Shepherd TM
    J Fam Pract; 2003 Jan; 52(1):34-42. PubMed ID: 12540311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New therapeutic options in obesity].
    Heufelder AE
    MMW Fortschr Med; 2003 Oct; 145(42):35-9. PubMed ID: 14655442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prudent and practical approach to the treatment of obesity.
    Kern PA
    J Ark Med Soc; 1997 Oct; 94(5):191-7. PubMed ID: 9343968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.
    Mason AE; Epel ES; Aschbacher K; Lustig RH; Acree M; Kristeller J; Cohn M; Dallman M; Moran PJ; Bacchetti P; Laraia B; Hecht FM; Daubenmier J
    Appetite; 2016 May; 100():86-93. PubMed ID: 26867697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The French are wary of their drugs].
    Nau JY
    Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke.
    Derby LE; Myers MW; Jick H
    Br J Clin Pharmacol; 1999 May; 47(5):565-9. PubMed ID: 10336582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma phentermine levels, weight loss and side-effects.
    Douglas A; Douglas JG; Robertson CE; Munro JF
    Int J Obes; 1983; 7(6):591-5. PubMed ID: 6654575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment of Weight Recidivism or Weight Loss Plateau Post-bariatric Surgery: a Retrospective Review.
    Schwartz J; Chaudhry UI; Suzo A; Durkin N; Wehr AM; Foreman KS; Tychonievich K; Mikami DJ; Needleman BJ; Noria SF
    Obes Surg; 2016 Feb; 26(2):452-8. PubMed ID: 26615406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Estimation of the influence of psychological support on body mass reduction in the obese patients].
    Ostrowska L; Karczewski J
    Wiad Lek; 2002; 55(3-4):174-82. PubMed ID: 12182002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases.
    DeMeo MT; Mobarhan S; Mikolaitis S; Kazi N
    Nutr Rev; 1997 Aug; 55(8):297-302. PubMed ID: 9287479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The influence of body mass reduction on metabolic disorders and complications in patient with morbid obesity. Three years observation].
    Pietrzak-Nowacka M; Safranow K; Kedzierska K
    Pol Arch Med Wewn; 2005 Jun; 113(6):575-9. PubMed ID: 16454448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attempting to lose weight: specific practices among U.S. adults.
    Kruger J; Galuska DA; Serdula MK; Jones DA
    Am J Prev Med; 2004 Jun; 26(5):402-6. PubMed ID: 15165656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity.
    Coutinho SR; Rehfeld JF; Holst JJ; Kulseng B; Martins C
    Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E91-E98. PubMed ID: 29360396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
    Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
    Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.